Supernus Pharmaceuticals (SUPN) Financials: Revenue & Earnings

SUPN price $40.31 -0.65 -1.59%

Ticker
SUPN
Price
$40.31
Change
-0.65 -1.59%
Market cap ?
$2.35B
P/E ?
-21.18
Forward P/E ?
16.90
Dividend yield ?
0.00%
Beta ?
0.55
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Financials

2016201720182019202020212022202320242025
215003000302238000408897000392755000520397000579775000667238000607521000661817000718952000

Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States. Its portfolio of marketed products includes Trokendi XR, an extended-release topiramate formulation prescribed for both epilepsy management and migraine prevention. Another key product is Oxtellar XR, an extended-release oxcarbazepine designed…

Fair value

SUPN fair value $91.73. Price $40.31. Price is 56% below fair value.

Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Average free cash flow, last three years 109.25M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 58.22M. Net debt -87.47M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare SUPN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—0.49—217.56M
2026-08-030.540.42219.06M205.31M
2026-05-050.590.28207.71M192.92M
2026-02-240.920.28211.57M195.16M
2025-11-041.010.82192.10M194.73M
2025-08-050.910.47165.45M168.23M
2025-05-060.420.38149.82M147.94M
2025-02-250.750.46174.16M155.25M
2024-11-041.060.39175.69M154.51M
2024-08-060.360.37168.32M148.83M
2024-05-080.260.38143.64M145.83M
2024-02-270.020.41164.31M155.03M
2023-11-08-0.290.13153.88M155.27M
2023-08-08-0.020.23135.56M143.66M
2023-05-090.290.17153.76M139.02M
2023-02-280.430.68167.33M180.33M
2022-11-080.030.36177.35M172.48M
2022-08-040.140.29170.05M164.13M
2022-05-090.430.26152.51M153.91M
2022-02-280.040.24159.05M148.38M
2021-11-030.400.23148.46M118.11M
2021-08-040.430.20141.33M134.87M
2021-05-050.110.24130.93M129.42M
2021-02-250.570.52143.56M146.19M
2020-11-030.740.30155.13M24.39M
2020-08-180.650.42126.73M81.89M
2020-05-050.400.2894.98M66.48M
2020-02-250.620.60100.45M97.21M
2019-11-050.540.60102.14M113.49M
2019-08-060.610.58104.69M99.55M
2019-05-070.340.4785.47M118.16M
2019-02-260.480.27115.93M95.65M
2018-11-060.520.41103.00M81.21M
2018-08-070.570.4399.54M75.09M
2018-05-080.490.3390.43M60.90M
2018-02-270.440.2688.44M54.27M
2017-11-060.290.2780.40M74.85M
2017-08-020.320.2475.83M56.87M
2017-05-090.190.2257.58M66.67M
2017-02-280.260.2562.37M59.97M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-12Khattar Jack A.Buy29.85K——
2026-08-12Khattar Jack A.Sell12.64K$46.57588.74K
2026-08-12Khattar Jack A.Sell29.85K——
2026-08-12Rubin JonathanBuy750——
2026-08-12Rubin JonathanSell363$46.5716.90K
2026-08-12Rubin JonathanSell750——
2026-08-12Bhatt Padmanabh P.Buy2.50K——
2026-08-12Bhatt Padmanabh P.Sell1.16K$46.5753.93K
2026-08-12Bhatt Padmanabh P.Sell2.50K——
2026-08-12Mottola FrankBuy1.65K——
2026-08-12Mottola FrankSell797$46.5737.12K
2026-08-12Mottola FrankSell1.65K——
2026-08-12DEC TIMOTHY CBuy1.25K——
2026-08-12DEC TIMOTHY CSell604$46.5728.13K
2026-08-12DEC TIMOTHY CSell1.25K——
2026-07-29Khattar Jack A.Buy29.85K——
2026-07-29DEC TIMOTHY CBuy1.25K——
2026-07-29Mottola FrankBuy1.65K——
2026-07-29Bhatt Padmanabh P.Buy2.50K——
2026-07-29Rubin JonathanBuy750——
2026-03-18Bhatt Padmanabh P.Buy7.25K$39.40285.65K
2026-03-18Bhatt Padmanabh P.Sell6.84K$49.55338.82K
2026-03-18Bhatt Padmanabh P.Sell412$50.4820.80K
2026-03-18Bhatt Padmanabh P.Sell7.25K$39.40285.65K
2026-03-17Bhatt Padmanabh P.Buy15.00K$38.60579.00K
2026-03-17Bhatt Padmanabh P.Buy12.25K$36.75450.19K
2026-03-17Bhatt Padmanabh P.Buy22.75K$39.40896.35K
2026-03-17Bhatt Padmanabh P.Sell27.71K$49.951.38M
2026-03-17Bhatt Padmanabh P.Sell22.29K$50.731.13M
2026-03-17Bhatt Padmanabh P.Sell22.75K$39.40896.35K
2026-03-17Bhatt Padmanabh P.Sell15.00K$38.60579.00K
2026-03-17Bhatt Padmanabh P.Sell12.25K$36.75450.19K
2026-03-16Bhatt Padmanabh P.Buy5.00K$27.94139.70K
2026-03-16Bhatt Padmanabh P.Buy18.00K$32.20579.60K
2026-03-16Bhatt Padmanabh P.Buy4.25K$29.61125.84K
2026-03-16Bhatt Padmanabh P.Buy22.75K$36.75836.06K
2026-03-16Bhatt Padmanabh P.Sell34.11K$50.181.71M
2026-03-16Bhatt Padmanabh P.Sell15.89K$50.49802.08K
2026-03-16Bhatt Padmanabh P.Sell5.00K$27.94139.70K
2026-03-16Bhatt Padmanabh P.Sell22.75K$36.75836.06K
2026-03-16Bhatt Padmanabh P.Sell18.00K$32.20579.60K
2026-03-16Bhatt Padmanabh P.Sell4.25K$29.61125.84K
2026-03-13Khattar Jack A.Buy12.50K——
2026-03-13Khattar Jack A.Sell12.50K——
2026-03-13Khattar Jack A.Sell24.14K$50.091.21M
2026-03-13Khattar Jack A.Sell10.74K$51.00547.84K
2026-03-13Khattar Jack A.Sell120$51.756.21K
2026-03-12Hudson Frederick M.Sell5.37K$50.61271.73K
2026-03-10Horich William ToddSell4.44K$55.00244.15K
2026-03-09Mottola FrankSell1.62K$53.6587.07K
2026-03-09Horich William ToddSell4.44K$54.00239.65K
2026-03-06Khattar Jack A.Buy38.64K——
2026-03-06Khattar Jack A.Sell16.57K$54.73907.10K
2026-03-06Khattar Jack A.Sell38.64K——
2026-03-06Mottola FrankBuy3.75K——
2026-03-06Mottola FrankSell1.79K$54.7398.13K
2026-03-06Mottola FrankSell3.75K——
2026-03-06DEC TIMOTHY CBuy3.00K——
2026-03-06DEC TIMOTHY CSell1.45K$54.7379.36K
2026-03-06DEC TIMOTHY CBuy3.00K——
2026-03-06DEC TIMOTHY CSell1.43K$54.7378.43K
2026-03-06DEC TIMOTHY CSell3.00K——
2026-03-06Horich William ToddBuy3.75K——
2026-03-06Horich William ToddBuy1.12K——
2026-03-06Horich William ToddSell521$54.7328.51K
2026-03-06Horich William ToddSell1.72K$54.7394.03K
2026-03-06Horich William ToddBuy2.62K——
2026-03-06Horich William ToddSell1.22K$54.7366.55K
2026-03-06Horich William ToddSell1.12K——
2026-03-06GEMAYEL GEORGESBuy7.91K$25.30200.00K
2026-03-06GEMAYEL GEORGESSell8.79K$53.00465.71K
2026-03-06GEMAYEL GEORGESSell7.91K$25.30200.00K
2026-03-05GEMAYEL GEORGESSell10.00K$53.71537.10K
2026-03-01Horich William ToddOther0——
2026-03-01Horich William ToddOther13.00K$39.40512.20K
2026-03-01Horich William ToddOther14.00K$36.75514.50K
2026-03-01Horich William ToddOther17.00K$29.61503.37K
2026-03-01Horich William ToddOther18.00K$32.20579.60K
2026-03-01Horich William ToddOther20.00K$38.60772.00K
2026-03-01Horich William ToddOther25.00K$27.94698.50K
2026-03-01Horich William ToddOther20.00K$33.52670.40K
2026-03-01Horich William ToddOther13.50K$50.20677.70K
2026-03-01Horich William ToddOther3.00K——
2026-03-01Horich William ToddOther2.62K——
2026-02-28Khattar Jack A.Buy38.64K——
2026-02-28DEC TIMOTHY CBuy3.00K——
2026-02-28Mottola FrankBuy3.75K——
2026-02-25Mottola FrankBuy1.88K——
2026-02-25Mottola FrankSell977$50.6949.52K
2026-02-25Mottola FrankSell1.88K——
2026-02-25DEC TIMOTHY CBuy2.50K——
2026-02-25DEC TIMOTHY CSell1.28K$50.6964.83K
2026-02-25DEC TIMOTHY CSell2.50K——
2026-02-25Bhatt Padmanabh P.Buy1.25K——
2026-02-25Bhatt Padmanabh P.Sell650$50.6932.95K
2026-02-25Bhatt Padmanabh P.Sell1.25K——
2026-02-25Rubin JonathanBuy1.25K——
2026-02-25Rubin JonathanSell675$50.6934.22K
2026-02-25Rubin JonathanSell1.25K——
2026-02-24DEC TIMOTHY CSell3.00K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 340, holders +5 vs prior quarter. Ownership 105.03%.

HolderSharesChangeChange %Value
BLACKROCK, INC.9.35M552.79K+6.28%434.87M
MILLENNIUM MANAGEMENT LLC3.85M537.24K+16.20%179.21M
VANGUARD PORTFOLIO MANAGEMENT LLC3.31M66.74K+2.06%153.74M
ARMISTICE CAPITAL, LLC2.65M750.85K+39.62%123.07M
VANGUARD CAPITAL MANAGEMENT LLC2.52M49.51K+2.01%117.05M
STATE STREET CORP2.46M171.70K+7.50%114.41M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.2.38M341.13K+16.74%110.62M
DIMENSIONAL FUND ADVISORS LP2.08M-228.94K-9.92%96.65M
GEODE CAPITAL MANAGEMENT, LLC1.57M-53.43K-3.29%73.04M
STEPHENS INVESTMENT MANAGEMENT GROUP LLC1.49M134.49K+9.95%69.11M
RENAISSANCE TECHNOLOGIES LLC1.48M-227.04K-13.31%68.75M
LOOMIS SAYLES & CO L P1.48M49.41K+3.47%68.61M
CITADEL ADVISORS LLC1.37M-119.46K-8.00%63.90M
TWO SIGMA INVESTMENTS, LP1.18M913.15K+336.67%55.09M
GW&K INVESTMENT MANAGEMENT, LLC1.04M-17.94K-1.70%48.24M
SOFINNOVA INVESTMENTS, INC.1.04M82.02K+8.59%48.20M
QUBE RESEARCH & TECHNOLOGIES LTD922.17K423.97K+85.10%42.89M
MORGAN STANLEY876.84K-37.05K-4.05%40.78M
GOLDMAN SACHS GROUP INC819.43K-37.05K-4.33%38.11M
D. E. SHAW & CO., INC.767.67K145.22K+23.33%35.70M
NORTHERN TRUST CORP733.37K33.92K+4.85%34.11M
WOODLINE PARTNERS LP708.28K259.28K+57.75%32.94M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.703.55K703.55KNew32.72M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC703.55K-2.42K-0.34%32.72M
BANK OF AMERICA CORP /DE/621.10K-93.12K-13.04%28.89M

Earnings and financials

Supernus Pharmaceuticals, Inc. (SUPN) trades at $40.31, with a market cap of $2.35B and a trailing P/E of -21.18. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
215003000302238000408897000392755000520397000579775000667238000607521000661817000718952000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Supernus Pharmaceuticals (SUPN) Financials: Revenue & Earnings

SUPN$40.31-0.65 -1.59%

$2.35B

Market Cap

-21.18

P/E

16.90

Forward P/E

—

Score

Price History